The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksJade Road Inv Regulatory News (JADE)

Share Price Information for Jade Road Inv (JADE)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1.375
Bid: 1.25
Ask: 1.50
Change: 0.00 (0.00%)
Spread: 0.25 (20.00%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 1.375
JADE Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Placement of shares

25 Aug 2023 11:56

RNS Number : 4997K
Jade Road Investments Limited
25 August 2023
 

25 August 2023

 

JADE ROAD INVESTMENTS LIMITED

("Jade Road Investments", "JADE", the "Company" or the "Group")

Placement of shares

 

Jade Road Investments Limited (AIM:JADE), the London quoted investment company that looks to provide investors exposure to alternative investments which aim to offer higher returns and lower risk than traditional asset classes, is pleased to announce the successful placing (the "Placing") of new ordinary shares of £0.001 each in the capital of the Company ("Ordinary Shares"). 

Subscription

A total of 36,866,667 new Ordinary Shares (the "Placing Shares") have been placed with investors at the price of 2.25 pence per Placing Share (the "Placing Price") raising gross proceeds of $1,050,000 (£829,500). 

The Placing Price represents a premium of approximately 20 per cent. to the closing mid-price of the Company's ordinary shares on 24 August 2023 and the Placing shares represent approximately 10.4 per cent. of the enlarged share capital.

The Company has paid Heirloom Investment Management LLC ('HIM') a 5% commission fee for introducing certain investors who are participating in the placing. The payment will be $40,000 to be received in shares in the Company at the placing price. The commission is a related party transaction under the Aim rules for Companies as HIM is a substantial shareholder in the Company. The Directors of the Company consider, having consulted with WH Ireland Limited, the Company's nominated adviser, that the terms of the transactions are fair and reasonable insofar as its shareholders are concerned.

John Croft, the Company's Chairman, commented: "We are delighted to welcome some new investors onto our share register facilitating the continuation of our new investment strategy focussed on income yielding alternative assets. The Placing provides the Company with adequate resources to continue its new investment program as well as meeting the interest payments due on its corporate bond and providing adequate working capital to support its operations in the near term."

 

Admission and Total Voting Rights

Application has been made to AIM for 36,866,667 shares to be admitted to trading on AIM, the admission date is expected to be on or around 1 September 2023.

In accordance with the provision of the Disclosure Guidance and Transparency Rules of the Financial Conduct Authority, the Company confirms that, following the issue of the Placing Shares its issued ordinary share capital will comprise 356,788,690 ordinary shares.

All of the ordinary shares have equal voting rights and 2,647,804 of the ordinary shares are held in Treasury. The total number of voting rights in the Company will therefore be 354,140,886. The above figure may be used by shareholders as the denominator for the calculations to determine if they are required to notify their interests in, or change to their interest in, the Company.

 

 

 

 

 

FOR FURTHER INFORMATION, PLEASE CONTACT:

 

Jade Road Investments Limited

+44 (0) 778 531 5588

John Croft

WH Ireland Limited - Nominated Adviser

+44 (0) 20 7220 1666

James Joyce

Andrew de Andrade

Hybridan LLP - Corporate Broker

+44 (0) 203 764 2341

Claire Noyce

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
IOEEAEPSASLDEFA
12
Date   Source Headline
1st May 20244:28 pmRNS2023 AGM Voting Results
8th Apr 20244:23 pmRNSPosting of Circular and Notice of AGM
3rd Apr 20243:58 pmRNSUpdates on Disposal of Legacy Assets
22nd Jan 20247:00 amRNSWebsite Update: Company Presentation and Q&A
5th Jan 20247:00 amRNSInvestor Meet Company Presentation
2nd Jan 20247:00 amRNSProposed Disposal of Legacy Assets & Restructuring
13th Dec 20237:00 amRNSOperational Update
15th Nov 20237:56 amRNSInvestment in Heirloom Litigation Finance
29th Sep 20237:00 amRNSINTERIM RESULTS FOR SIX MONTHS ENDED 30 JUNE 2023
4th Sep 20237:00 amRNSPlacement of Shares
25th Aug 202311:56 amRNSPlacement of shares
26th Jul 20232:10 pmRNSSecond Supplemental Bond Instrument Update
17th Jul 202311:37 amRNSUpdate on Interest Payment to Bondholders
3rd Jul 20235:45 pmRNSBond Interest Payment Update, Proposed Fundraising
26th May 20232:06 pmRNS2022 AGM Voting Results
26th May 20231:16 pmRNSFinal Results
9th May 20237:00 amRNSCorrection: Finding a Genuine Alternative
5th May 20231:57 pmRNSFinding a Genuine Alternative
5th Apr 20237:00 amRNSNew Investment
27th Mar 20237:00 amRNSRevision to Investment Management Agreement
24th Mar 202310:56 amRNSBoard Change
13th Mar 20234:40 pmRNSSecond Price Monitoring Extn
13th Mar 20234:35 pmRNSPrice Monitoring Extension
6th Mar 20234:40 pmRNSSecond Price Monitoring Extn
6th Mar 20234:35 pmRNSPrice Monitoring Extension
21st Feb 20237:00 amRNSResults of General Meeting
20th Feb 20237:00 amRNSCompletion of Conditional Equity Fundraise
31st Jan 20233:45 pmRNSReplacement Circular
31st Jan 20238:44 amRNSCirc re. Investing Policy, Proposed Placing & GM
1st Dec 202211:19 amRNSUS Dollar-denominated Corporate Bonds
21st Oct 20227:42 amRNSUS Dollar-denominated corporate bonds
22nd Sep 202211:59 amRNSINTERIM RESULTS FOR SIX MONTHS ENDED 30 JUNE 2022
18th Aug 20224:41 pmRNSSecond Price Monitoring Extn
18th Aug 20224:35 pmRNSPrice Monitoring Extension
18th Aug 20222:28 pmRNSPartial Divestment in Meize Energy Industries
17th Aug 20229:05 amRNSSecond Price Monitoring Extn
17th Aug 20229:00 amRNSPrice Monitoring Extension
1st Aug 202211:05 amRNSSecond Price Monitoring Extn
1st Aug 202211:00 amRNSPrice Monitoring Extension
1st Aug 20229:05 amRNSSecond Price Monitoring Extn
1st Aug 20229:00 amRNSPrice Monitoring Extension
20th Jul 20228:36 amRNSPartial Divestment in Meize Energy Industries
1st Jul 202210:29 amRNSReplacement for Final Results
30th Jun 20227:00 amRNSFinal Results
22nd Jun 20227:39 amRNSPartial divestment in Meize Energy Industries
20th May 20224:41 pmRNSSecond Price Monitoring Extn
20th May 20224:36 pmRNSPrice Monitoring Extension
17th Dec 20219:06 amRNSSecond Price Monitoring Extn
17th Dec 20219:00 amRNSPrice Monitoring Extension
17th Dec 20217:00 amRNSUPDATE ON FOOK LAM MOON HOLDINGS
12

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.